These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Micro-vacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Comparison of effects of ethanolamine-O-sulphate and vigabatrin. John RA; Rimmer EM; Williams J; Cole G; Fowler LJ; Richens A Biochem Pharmacol; 1987 May; 36(9):1467-73. PubMed ID: 3579985 [TBL] [Abstract][Full Text] [Related]
16. Drugs recently released in Belgium. Bopindolol--vigabatrin. Harvengt C Acta Clin Belg; 1991; 46(5):345-8. PubMed ID: 1684461 [No Abstract] [Full Text] [Related]
17. The neuropathology of vigabatrin. Butler WH Epilepsia; 1989; 30 Suppl 3():S15-7. PubMed ID: 2767014 [TBL] [Abstract][Full Text] [Related]
18. Vigabatrin--interference with urinary amino acid analysis. Preece MA; Sewell IJ; Taylor JA; Green A Clin Chim Acta; 1993 Sep; 218(1):113-6. PubMed ID: 8299214 [No Abstract] [Full Text] [Related]
19. Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease. Turjanski N; Lees AJ J Neurol Neurosurg Psychiatry; 1992 May; 55(5):413. PubMed ID: 1602321 [No Abstract] [Full Text] [Related]
20. Recommendations for visual evaluations of patients treated with vigabatrin. Sergott RC Curr Opin Ophthalmol; 2010 Nov; 21(6):442-6. PubMed ID: 20811279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]